Insider · CIK 0001187333
Hollings Renton
director
Files at ANAB (ANAPTYSBIO, INC). First filing Dec 3, 2024, latest Oct 2, 2026.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 5
$0 bought, $1.3M sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
ANAB: ANAPTYSBIO, INC
ANABOct 9, 2026 · close 45.95
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 3Weak | ANAPTYSBIO, INC | $249k 5,000 shares | -31% | +144% from low-30% from high | |
| 12Weak | ANAPTYSBIO, INC | $201k 10,231 shares | -67% | +70% from low-48% from high | |
| 26Weak | ANAPTYSBIO, INC | $493k 20,925 shares | -81% | +93% from low-41% from high | |
| 21Weak | ANAPTYSBIO, INC | $72k 3,015 shares | -38% | +89% from low-42% from high | |
| 13Weak | ANAPTYSBIO, INC | $250k 10,000 shares | -84% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 1, 2026 | ANAB ANAPTYSBIO, INC | MOption exercise Common Stock10b5-1 | +5,000 | $18.03 | $90k | 15,995 | 10 d ago |
| Oct 1, 2026 | ANAB ANAPTYSBIO, INC | SOpen-market sale Common Stock10b5-1 | -5,000 | $49.87 | $249k | 10,995 | 10 d ago |
| Oct 1, 2026 | ANAB ANAPTYSBIO, INC | MOption exercise Common Stockderivative10b5-1 | -5,000 | $0.00 | $0 | 10,000 | 10 d ago |
| Aug 8, 2025 | ANAB ANAPTYSBIO, INC | MOption exercise Common Stock10b5-1 | +10,231 | $6.93 | $71k | 15,196 | Aug 12, 2025 |
| Aug 8, 2025 | ANAB ANAPTYSBIO, INC | SOpen-market sale Common Stock10b5-1 | -3,110 | $19.44 | $60k | 12,086 | Aug 12, 2025 |
| Aug 8, 2025 | ANAB ANAPTYSBIO, INC | SOpen-market sale Common Stock10b5-1 | -7,121 | $19.70 | $140k | 4,965 | Aug 12, 2025 |
| Aug 8, 2025 | ANAB ANAPTYSBIO, INC | MOption exercise Common Stockderivative10b5-1 | -10,231 | $0.00 | $0 | 0 | Aug 12, 2025 |
| Jul 2, 2025 | ANAB ANAPTYSBIO, INC | MOption exercise Common Stock10b5-1 | +20,925 | $6.93 | $145k | 25,890 | Jul 3, 2025 |
| Jul 2, 2025 | ANAB ANAPTYSBIO, INC | SOpen-market sale Common Stock10b5-1 | -7,250 | $23.09 | $167k | 18,640 | Jul 3, 2025 |
| Jul 2, 2025 | ANAB ANAPTYSBIO, INC | SOpen-market sale Common Stock10b5-1 | -13,675 | $23.82 | $326k | 4,965 | Jul 3, 2025 |
| Jul 2, 2025 | ANAB ANAPTYSBIO, INC | MOption exercise Common Stockderivative10b5-1 | -20,925 | $0.00 | $0 | 0 | Jul 3, 2025 |
| Jun 18, 2025 | ANAB ANAPTYSBIO, INC | SOpen-market sale Common Stock10b5-1 | -3,015 | $23.97 | $72k | 4,965 | Jun 20, 2025 |
| Jun 15, 2025 | ANAB ANAPTYSBIO, INC | MOption exercise Common Stock | +6,030 | $0.00 | $0 | 7,980 | Jun 17, 2025 |
| Jun 15, 2025 | ANAB ANAPTYSBIO, INC | MOption exercise Restricted Stock Unitderivative | -6,030 | $0.00 | $0 | 0 | Jun 17, 2025 |
| Jan 7, 2025 | ANAB ANAPTYSBIO, INC | AGrant or award Stock Option (right to buy)derivative | +16,510 | $0.00 | $0 | 16,510 | Jan 7, 2025 |
| Jan 7, 2025 | ANAB ANAPTYSBIO, INC | AGrant or award Restricted Stock Unitderivative | +6,030 | $0.00 | $0 | 6,030 | Jan 7, 2025 |
| Nov 29, 2024 | ANAB ANAPTYSBIO, INC | MOption exercise Common Stock10b5-1 | +10,000 | $6.93 | $69k | 11,950 | Dec 3, 2024 |
| Nov 29, 2024 | ANAB ANAPTYSBIO, INC | SOpen-market sale Common Stock10b5-1 | -10,000 | $25.00 | $250k | 1,950 | Dec 3, 2024 |
| Nov 29, 2024 | ANAB ANAPTYSBIO, INC | MOption exercise Common Stockderivative10b5-1 | -10,000 | $0.00 | $0 | 20,925 | Dec 3, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.